A Tumor-suppressive Role for Trypsin in Human Cancer Progression

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6575-6578

  Yamashita, Keishi ^a,b   Mimori, Koshi ^b   Inoue, Hiroshi ^b   Mori, Masaki ^b   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEINASE ACTIVATED RECEPTOR 2; RNA; SERINE PROTEINASE; TRYPSIN; TRYPSINOGEN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; REDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH WALL;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STOMACH NEOPLASMS; TRYPSIN; TRYPSINOGEN;

EID: 0142250910     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tani, T., Kawashima, I., Mita, K., and Takiguchi, Y. Nucleotide sequence of the human pancreatic trypsinogen III cDNA. Nucleic Acids Res., 18: 1631, 1990.
2. Minn, A., Schubert, M., Neiss, W., and Muller-Hill, B. Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV. Glia, 22: 338-347, 1998.
3. Grinhlatt, J. A. Measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N. Engl. J. Med., 337: 1394-1395, 1998.
4. Creighton, J., Lyall, R., Wilson, D. I., Curtis, A., and Charnley, R. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet, 354: 42-43, 1999.
5. Cocks, T., Fong, B., Chow, J., Anderson, G., Frauman, A., Goldie, R., Henry, P., Cart, M., Hamilton, J., and Moffatt, J. A protective role for protease-activated receptors in the airways. Nature (Lond.), 398: 156-160, 1999.
6. Koivunen, E., Saksela, O., Itkonen, O., Osman, S., Huhtala, M., and Stenman, U. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int. J. Cancer, 47: 592-596, 1991.
7. Hirahara, F., Miyagi, Y., Miyagi, E., Yasumitsu, H., Koshikawa, N., Nagashima, Y., Kitamura, H., Minaguchi, H., Umeda, M., and Miyazaki, K. Trypsinogen expression in human ovarian carcinomas. Int. J. Cancer, 63: 176-181, 1995.
8. Ohta, T., Terada, T., Nagakawa, T., Tajima, H., Itoh, H., Fonseca, L., and Miyazaki, I. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br. J. Cancer, 69: 152-156, 1994.
9. Koshikawa, N., Yasumitsu, H., Umeda, M., and Miyazaki, K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res., 52: 5046-5053, 1992.
10. Li, Q-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K-I., Chi, X-Z., Lee, K-Y., Nomura, S., Lee, C-W., Han, S-B., Kim, H-M., Kim, W-J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S-C., and Ito, Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 109: 113-124, 2002.
11. Yamashita, K., Upadhay, S., Osada, M., Mohammad, O. H., Xiao, Y., Mori, M., Sato, F., Meltzer, S. J., and Sidransky, D. Pharmacological unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell, 2: 485-500, 2002.
12. Yamashita, K., Mori, M., Shiraishi, T., Shibuta, K., and Sugimachi, K. Clinical significance of matrix metalloproteinase-7 in esophageal carcinoma. Clin. Cancer Res., 6: 1169-1174, 2000.
13. Yamashita, K., Mori, M., Kataoka, A., Inoue, H., and Sugimachi, K. The clinical significance of MMP-1 expression in oesophageal carcinoma. Br. J. Cancer, 84: 276-282, 2001.
14. Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G., and Baylin, S. B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21: 103-107, 1999.
15. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., Van Engeland, M., Weijenberg, M. P., Herman, J. G., and Baylin, S. B. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 31: 141-149, 2002.
16. Ohta, T., Tajima, H., and Terada, T. Cationic trypsinogen produced by human pancreatic ductal cancer has the characteristics of spontaneous activation and gelatinolytic activity in the presence of proton. Int. J. Mol. Med., 1: 689-692, 1998.
17. Kato, Y., Nagashima, Y., Koshikawa, N., Miyagi, Y., Yasumitsu, H., and Miyazaki, K. Production of trypsins by human gastric cancer cells correlates with their malignant phenotype. Eur. J. Cancer, 34: 1117-1123, 1998.
18. Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y., Bergmann, U., Tuuttila, A., Niemi, E., Teronen, O., Heikkila, P., Tschesehe, H., Leinonen, J., Osman, S., and Stenman, U. Activation of type IV procollagenases by human tumor-associated trypsin-2. J. Biol. Chem., 272: 21067-21074, 1997.
19. Patel, Y., Rahman, S., Siddiqua, A., Wilkinson, J. M., Kakkar, V. V., and Authi, K. S. Functional characterization of PM6/13, a β3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Thromb. Haemost., 79: 177-185, 1998.
20. Yawata, A., Adachi, M., Okuda, H., Naishiro, Y., Takamura, T., Hareyama, M., Takayama, S., Reed, J. C., and Imai, K. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene, 16: 2681-2686, 1998.